ofa vs fda tirzepatide UPDATE [March 7, 2025]: takes case to appeals court as legal battle evolves Switching Between Semaglutide and Tirzepatide:

The Tirzepatide group showed greater weight reduction (-10.7 kg) with 15 mg, compared to dulaglutide (-0.5 kg)

These modifications enhance its resistance to enzymatic breakdown and facilitate prolonged receptor interaction, making it suitable for sustained signaling studies compared to natural incretin hormones

The Outsourcing Facilities Association (OFA), a Texas-based trade association focused on distributing compounded medications, sued the FDA over its October decision, arguing that the agency did not give enough notice to the necessary stakeholders

if you experience chest pain, shortness of breath, or fainting, seek emergency evaluation

JAMA (2022) 6